Market Cap : 21.56 B | Enterprise Value : 22.47 B | P/E (TTM) : 52.17 | P/B : 106.64 |
---|
NAS:IDXX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:IDXX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, IDEXX Laboratories's Enterprise Value is USD 22,467 Mil. IDEXX Laboratories's EBIT for the trailing twelve months (TTM) ended in Sep. 2019 was USD 553 Mil. Therefore, IDEXX Laboratories's EV-to-EBIT for today is 40.63.
During the past 13 years, the highest EV-to-EBIT of IDEXX Laboratories was 50.70. The lowest was 10.60. And the median was 23.65.
Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. IDEXX Laboratories's Enterprise Value for the quarter that ended in Sep. 2019 was USD 24,260 Mil. IDEXX Laboratories's EBIT for the trailing twelve months (TTM) ended in Sep. 2019 was USD 553 Mil. IDEXX Laboratories's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2019 was 2.28%.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
* The bar in red indicates where IDEXX Laboratories's EV-to-EBIT falls into.
IDEXX Laboratories's EV-to-EBIT for today is calculated as:
EV-to-EBIT | = | Enterprise Value (Today) | / | EBIT (TTM) |
= | 22466.745 | / | 552.979 | |
= | 40.63 |
IDEXX Laboratories's current Enterprise Value is USD 22,467 Mil.
IDEXX Laboratories's EBIT for the trailing twelve months (TTM) ended in Sep. 2019 was 115.605 (Dec. 2018 ) + 133.178 (Mar. 2019 ) + 164.308 (Jun. 2019 ) + 139.888 (Sep. 2019 ) = USD 553 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
This is a more accurate valuation of companies' operation because it consider the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.
IDEXX Laboratories's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2019 is calculated as:
Earnings Yield (Joel Greenblatt) % (Q: Sep. 2019 | = | EBIT | / | Enterprise Value (Q: Sep. 2019 ) |
= | 552.979 | / | 24259.6527 | |
= | 2.28 % |
IDEXX Laboratories's Enterprise Value for the quarter that ended in >Sep. 2019 was USD 24,260 Mil.
IDEXX Laboratories's EBIT for the trailing twelve months (TTM) ended in Sep. 2019 was 115.605 (Dec. 2018 ) + 133.178 (Mar. 2019 ) + 164.308 (Jun. 2019 ) + 139.888 (Sep. 2019 ) = USD 553 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
No Headline